Page 51 - congress
P. 51
ORAL PRESENTATION / TAM METİN SÖZLÜ SUNUM
deficits and cognitive impairment in autism spectrum disorder-like phenotype in rats.
Pharmacology Biochemistry and Behavior. 174:030.
Tang G, Rios PG, Kuo SH, Akman HO, Rosoklija G, Tanji K, et al. (2013). Mitochondrial
abnormalities in temporal lobe of autistic brain. Neurobiology of Disease. 54:349-361.
Tiwari R, Purkayastha K, Gulati S. (2021). Public health dimensions of autism spectrum disorder
in India: An overview. Journal of Comprehensive Health. 9(2):57-62.
Tristano AG. (2010). Neurological adverse events associated with anti-tumor necrosis factor alpha
treatment. Journal of Neurology. 257(9):1421-1431.
Wen Y, Yao Y. (2021). Autism spectrum disorders: the mitochondria connection. In: Exon
Publications; p:79–93.
Yenkoyan K, Harutyunyan H, Harutyunyan A. (2018). A certain role of SOD/CAT imbalance in
pathogenesis of autism spectrum disorders. Free Radical Biology and Medicine. 123, 85-
95.
Yu AW, Pecsok M, Longbrake EE, Wesley SF. (2021). Neuroinflammation associated with tumor
necrosis factor-α inhibitor exposure. Neurology: Clinical Practice. 11(4), e488–e496.
Zhou Y, Fan R, Botchway BO, Zhang Y, Liu X. (2021). Infliximab can improve traumatic brain injury
by suppressing the tumor necrosis factor alpha pathway. Molecular Neurobiology. 58(6),
2803–2811.
49
